DrugPatentWatch Database Preview
Cefotetan disodium - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for cefotetan disodium and what is the scope of freedom to operate?
Cefotetan disodium
is the generic ingredient in four branded drugs marketed by Teligent, Teligent Pharma Inc, Fresenius Kabi Usa, Hikma, West-ward Pharm Corp, and B Braun, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for cefotetan disodium. Four suppliers are listed for this compound.
Summary for cefotetan disodium
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 6 |
NDAs: | 8 |
Drug Master File Entries: | 3 |
Suppliers / Packagers: | 4 |
Bulk Api Vendors: | 27 |
Clinical Trials: | 1 |
Patent Applications: | 1,189 |
Drug Prices: | Drug price trends for cefotetan disodium |
DailyMed Link: | cefotetan disodium at DailyMed |
Recent Clinical Trials for cefotetan disodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
Pharmacology for cefotetan disodium
Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for cefotetan disodium
Synonyms for cefotetan disodium
(6R,7S)-4-((2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-delta(sup 2,alpha)-malonamic acid, disodium salt |
(6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, disodium salt |
0GXP746VXB |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethyl)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6R-cis)- |
69712-56-7 (Parent) |
74356-00-6 |
AC1L1E30 |
AKOS025311215 |
AN-37204 |
Apatef |
C14007 |
C17H15N7O8S4.2Na |
C17H17N7O8S4.2Na |
Cefotan |
Cefotan (TN) |
CEFOTAN IN PLASTIC CONTAINER |
Cefotetan and dextrose in duplex container |
Cefotetan disodium (USP) |
Cefotetan disodium [USAN:USP] |
Cefotetan disodium [USAN] |
Cefotetan disodium salt |
Cefotetan disodium, Antibiotic for Culture Media Use Only |
cefotetan sodium |
Cefotetan sodium (JAN) |
Ceftenon |
Cepan |
CHEBI:34617 |
CHEMBL1201098 |
D02228 |
Darvilen |
disodium (6R,7S)-7-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
disodium (6R,7S)-7-[[4-(1-amino-3-oxido-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
disodium (6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxo-ethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
Disodium (7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
disodium 7beta-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylate |
Disodium(7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
EINECS 277-834-9 |
FT-0645368 |
ICI 156834 disodium |
ICI-156834 |
LS-149943 |
M153 |
PubChem19005 |
SCHEMBL40794 |
sodium (6R,7S)-7-(4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
UNII-0GXP746VXB |
Yamatetan |
YM 09330 |
YM-09330 |
US Patents and Regulatory Information for cefotetan disodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | CEFOTETAN | cefotetan disodium | INJECTABLE;INJECTION | 091031-002 | Oct 26, 2011 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
West-ward Pharm Corp | CEFOTETAN | cefotetan disodium | INJECTABLE;INJECTION | 091030-001 | Oct 26, 2011 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Teligent | CEFOTAN | cefotetan disodium | INJECTABLE;INJECTION | 050588-003 | Apr 25, 1988 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Teligent Pharma Inc | CEFOTAN | cefotetan disodium | INJECTABLE;INJECTION | 063293-001 | Apr 29, 1993 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.